• Reuters
Plans by US biotech company Dendreon Corp. to market a pioneering therapeutic cancer vaccine, Provenge, were dealt a blow on Wednesday when US regulators demanded more data before approving it.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: